URMC Research Network - Brent DuBeshter

Find People

Brent DuBeshter

Title	Professor
Institution	School of Medicine and Dentistry
Department	Obstetrics and Gynecology
Address	University of Rochester Medical Center School of Medicine and Dentistry 601 Elmwood Ave, Box 668 Rochester NY 14642

Awards And Honors

1974			ACS Merit Award
1974			Phi Beta Kappa
1978			Raven Society \| University of Virginia
2004			CREOG National Faculty Award for Teaching Excellence
2004			Who's Who in Medical Science Education
2005			Who's Who of Executives and Professionals
2005			Obstetrics & Gynecology - Top Reviewer
2008			Americas Top Oncologists \| Consumer Research Council of America
2010	-	2011	Patient's Choice and Compassionate Doctor Award
2012			US News Top Doctor Recognition

Overview

Dr. DuBeshter is the Director of Gynecologic Oncology and Professor of Obstetrics & Gynecology for the University of Rochester Medical Center. Dr. DuBeshter earned his undergraduate degree with honors and distinction in research from Franklin & Marshall College and his medical degree from the University of Virginia. He completed his residency in obstetrics & gynecology and a fellowship in gynecologic oncology at Brigham & Women's Hospital and Harvard Medical School.

Dr. DuBeshter has contributed to numerous journal, abstracts, and books, including the chapter on gynecologic cancer in the textbook Clinical Oncology: A Multidisciplinary Approach. He is also the co-developer of IntelliDose software, a computer programs used internationally with over 100 domestic sites that safeguards patients undergoing chemotherapy treatment.

Dr. DuBeshter is certified by the American Boards of Obstetrics & Gynecology and Gynecologic Oncology. He is a member of the International Gynecologic Cancer Society and the Society of Gynecologic Oncologists, as well as the American Society of Clinical Oncology. He currently serves on the Clinical Practice and Finance Committee of the Society of Gynecologic Oncologists and is a reviewer for Obstetrics & Gynecology, Gynecologic Oncology, and the International Journal of Gynecologic Cancer.

Selected Publications

Reynolds EA, DuBeshter B, Katzman P, Larson K, Katzel S, Glantz C. Expression of CD44, E-cadherin, and antimetastatic protein nm23-H1 in complete hydatidiform moles. Gynecol Oncol. 2007 Feb; 104(2):451-4.

View in: PubMed
Dubeshter B, Walsh CJ, Altobelli K, Loughner J, Angel C. Experience with computerized chemotherapy order entry. J Oncol Pract. 2006 Mar; 2(2):49-52.

View in: PubMed
Brown AK, Gillis S, Deuel C, Angel C, Glantz C, Dubeshter B. Abnormal cervical cytology: a risk factor for endometrial cancer recurrence. Int J Gynecol Cancer. 2005 May-Jun; 15(3):517-22.

View in: PubMed
Thigpen JT, Brady MF, Homesley HD, Malfetano J, DuBeshter B, Burger RA, Liao S. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol. 2004 Oct 1; 22(19):3902-8.

View in: PubMed
DuBeshter B, Estler K, Altobelli K, McDonald S, Glantz C, Angel C. High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer. Gynecol Oncol. 2004 Aug; 94(2):383-6.

View in: PubMed
Hosford S, Elliott J, Ma ZW, Majeste R, Dubeshter B. CD44 expression in papillary serous endometrial carcinoma. Int J Gynecol Cancer. 2003 Jul-Aug; 13(4):480-4.

View in: PubMed
DuBeshter B, Deuel C, Gillis S, Glantz C, Angel C, Guzick D. Endometrial cancer: the potential role of cervical cytology in current surgical staging. Obstet Gynecol. 2003 Mar; 101(3):445-50.

View in: PubMed
Arkoulakis NS, Angel CL, DuBeshter B, Serletti JM. Reconstruction of an extensive vulvectomy defect using the gluteus maximus fasciocutaneous V-Y advancement flap. Ann Plast Surg. 2002 Jul; 49(1):50-4; discussion 54.

View in: PubMed
Morrow GR, Hickok JT, DuBeshter B, Lipshultz SE. Changes in clinical measures of autonomic nervous system function related to cancer chemotherapy-induced nausea. J Auton Nerv Syst. 1999 Oct 8; 78(1):57-63.

View in: PubMed
DuBeshter B. Endometrial cancer: predictive value of cervical cytology. Gynecol Oncol. 1999 Mar; 72(3):271-2.

View in: PubMed
Alberts DS, Liu PY, Hannigan EV, O'Toole R, Williams SD, Young JA, Franklin EW, Clarke-Pearson DL, Malviya VK, DuBeshter B. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med. 1996 Dec 26; 335(26):1950-5.

View in: PubMed
Muth ER, Morrow GR, Jiang W, Stern RM, Dubeshter B. Cardiac spectral power reflects parasympathetic but not sympathetic nervous system activity in a clinical population. J Auton Nerv Syst. 1996 Nov 6; 61(2):201-3.

View in: PubMed
Warshal DP, Fultz PJ, Dawson AE, Del Priore G, DuBeshter B. Interstitial pregnancy complicated by rectal bleeding. Am J Obstet Gynecol. 1996 Nov; 175(5):1373-5.

View in: PubMed
Markman M, Iseminger KA, Hatch KD, Creasman WT, Barnes W, Dubeshter B. Tamoxifen in platinum-refractory ovarian cancer: a Gynecologic Oncology Group Ancillary Report. Gynecol Oncol. 1996 Jul; 62(1):4-6.

View in: PubMed
Wilbur DC, Dubeshter B, Angel C, Atkison KM. Use of thin-layer preparations for gynecologic smears with emphasis on the cytomorphology of high-grade intraepithelial lesions and carcinomas. Diagn Cytopathol. 1996 May; 14(3):201-11.

View in: PubMed
Del Priore G, Gurski KJ, Warshal DP, Angel C, Dubeshter B. Adrenal function following high-dose steroids in ovarian cancer patients. Gynecol Oncol. 1995 Oct; 59(1):102-4.

View in: PubMed
Del Priore G, Smith P, Warshal DP, Dubeshter B, Angel C. Paclitaxel-associated hypersensitivity reaction despite high-dose steroids and prolonged infusions. Gynecol Oncol. 1995 Feb; 56(2):316-8.

View in: PubMed
Bellg AJ, Morrow GR, Barry M, Angel C, DuBeshter B. Autonomic measures associated with chemotherapy-related nausea: techniques and issues. Cancer Invest. 1995; 13(3):313-23.

View in: PubMed
Jaffe R, DuBeshter B, Sherer DM, Thompson EA, Woods JR. Failure of methotrexate treatment for term placenta percreta. Am J Obstet Gynecol. 1994 Aug; 171(2):558-9.

View in: PubMed
Muss HB, Blessing JA, DuBeshter B. Echinomycin in recurrent and metastatic endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group. Am J Clin Oncol. 1993 Dec; 16(6):492-3.

View in: PubMed
Abulafia O, DuBeshter B, Dawson AE, Sherer DM. Presence of cytomegalovirus inclusion bodies in a recurrent ulcerative vaginal lesion. Am J Obstet Gynecol. 1993 Nov; 169(5):1179-80.

View in: PubMed
Sherer DM, Abulafia O, DuBeshter B, Cox C, Woods JR. Ultrasonographically guided subclavian vein catheterization in critical care obstetrics and gynecologic oncology. Am J Obstet Gynecol. 1993 Nov; 169(5):1246-8.

View in: PubMed
Abulafia O, Angel C, Sherer DM, Fultz PJ, Bonfiglio TA, DuBeshter B. Computed tomography of leiomyomatosis peritonealis disseminata with malignant transformation. Am J Obstet Gynecol. 1993 Jul; 169(1):52-4.

View in: PubMed
Lin JY, Angel C, DuBeshter B, Walsh CJ. Diagnoses after laparotomy for a mass in the pelvic area in women. Surg Gynecol Obstet. 1993 Apr; 176(4):333-8.

View in: PubMed
Angel C, DuBeshter B, Dawson AE, Keller J. Recurrent stage I endometrial adenocarcinoma in the nonirradiated patient: preliminary results of surgical "staging". Gynecol Oncol. 1993 Feb; 48(2):221-6.

View in: PubMed
Morrow GR, Angel C, Dubeshter B. Autonomic changes during cancer chemotherapy induced nausea and emesis. Br J Cancer Suppl. 1992 Dec; 19:S42-5.

View in: PubMed
Lin JY, DuBeshter B, Angel C, Dvoretsky PM. Morbidity and recurrence with modifications of radical vulvectomy and groin dissection. Gynecol Oncol. 1992 Oct; 47(1):80-6.

View in: PubMed
Angel C, DuBeshter B, Lin JY. Clinical presentation and management of stage I cervical adenocarcinoma: a 25 year experience. Gynecol Oncol. 1992 Jan; 44(1):71-8.

View in: PubMed
DuBeshter B, Warshal DP, Angel C, Dvoretsky PM, Lin JY, Raubertas RF. Endometrial carcinoma: the relevance of cervical cytology. Obstet Gynecol. 1991 Mar; 77(3):458-62.

View in: PubMed
DuBeshter B, Berkowitz RS, Goldstein DP, Bernstein MR. Management of low-risk metastatic gestational trophoblastic tumors. J Reprod Med. 1991 Jan; 36(1):36-9.

View in: PubMed
DuBeshter B. High-risk factors in metastatic gestational trophoblastic neoplasia. J Reprod Med. 1991 Jan; 36(1):9-13.

View in: PubMed
DuBeshter B, Berkowitz RS, Goldstein DP, Bernstein M. Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease. J Reprod Med. 1989 Mar; 34(3):189-92.

View in: PubMed
DuBeshter B, Berkowitz RS, Goldstein DP, Bernstein MR. Analysis of treatment failure in high-risk metastatic gestational trophoblastic disease. Gynecol Oncol. 1988 Feb; 29(2):199-207.

View in: PubMed
Berkowitz RS, Goldstein DP, DuBeshter B, Bernstein MR. Management of complete molar pregnancy. J Reprod Med. 1987 Sep; 32(9):634-9.

View in: PubMed
DuBeshter B, Berkowitz RS, Goldstein DP, Cramer DW, Bernstein MR. Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center, 1965 to 1985. Obstet Gynecol. 1987 Mar; 69(3 Pt 1):390-5.

View in: PubMed